Michihiro Uchiyama (Dept of Hematol., Suwa Red Cross Hospital, Nagano, Japan)
Session information
Oral Session
Oral Session 2-10A Indolent Lymphoma: Treatment
Sat. Oct 12, 2019 9:00 AM - 10:00 AM No.10 (Tokyo International Forum, 4F G409)
Chair: Ilseung Choi (Dep. Hematology, NHO Kyushu Cancer Center)
Ayaka Kume1, Akira Toriihara2, Ryo Shimizu1, Naoki Harada3, Jun Isogai3, Hiroaki Tanaka1 (1.Department of Hematology, Asahi General Hospital, Chiba, Japan, 2.Department of Nuclear Medicine, Asahi General Hospital, Chiba, Japan, 3.Department of Radiology, Asahi General Hospital, Chiba, Japan)
Ye Ding, Naoko Handa, Kei Nishikawa, Toshiko Motoji, Tomohiro Myojo, Hiroshi Osawa (Department of oncology and hematology, Edogawa Hospital)
Keiichi Nakata, Shigeo Fuji, Ryo Nakata, Shuhei Kida, Kazuhito Tsutsumi, Midori Koike, Yuma Tada, Hiroaki Masaie, Hitoshi Yoshida, Jun Ishikawa (Department of Hematology, Osaka International Cancer Institute)
Sayaka Ohno, Katsuyoshi Horiuchi, Yuri Tamura, Yuhei Nagao, Katsuhiro Shono, Masahiro Onoda, Akira Yokota (Department of Hematology, Chiba Aoba Municipal Hospital)
Norihito Inoue1, Yuko Shirouchi1, Takanori Fukuta1, Yoshiharu Kusano1, Hideki Uryu1, Takashi Okabe1, Yuko Mishima1, Noriko Nishimura1, Masahiro Yokoyama1, Naoko Tsuyama2, Kengo Takeuchi2, Yasuhito Terui1 (1.Hematology Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Pathology, The Cancer Institute of JFCR, Tokyo, Japan)